Intestine-specific expression of Apobec-1 rescues apolipoprotein B RNA editing and alters chylomicron production in Apobec1-/- mice

Journal of Lipid Research

Volumn 53, Issue 12, 2012, Pages 2643-2655

  Blanc, Valerie ^a   Xie, Yan ^a   Luo, Jianyang ^a   Kennedy, Susan ^a   Davidson, Nicholas O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ApoB48; Cytidine deaminase; Hyperediting; Lipoprotein assembly; RNA binding

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHYLOMICRON; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VIVO STUDY; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; LIVER; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EDITING; SMALL INTESTINE;

ANIMALS; APOLIPOPROTEINS B; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHYLOMICRONS; CYTIDINE DEAMINASE; INTESTINE, SMALL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON; ORGAN SPECIFICITY; RNA EDITING; RNA, MESSENGER;

EID: 84869013037     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M030494     Document Type: Article

References (37)

1. Chen, Z., and Davidson, N.O. 2006. Genetic regulation of intestinal lipid transport and metabolism. In Physiology of the Gastrointestinal Tract. L. R. Johnson, editor. Elsevier Academic Press, Boston, MA. 1711-1734.
2. Hussain, M. M., P. Rava, M. Walsh, M. Rana, and J. Iqbal. 2012. Multiple functions of microsomal triglyceride transfer protein. Nutr. Metab. (Lond). 9: 14.
3. Teng, B., C. F. Burant, and N. O. Davidson. 1993. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 260: 1816-1819.
4. Mehta, A., M. T. Kinter, N. E. Sherman, and D. M. Driscoll. 2000. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol. Cell. Biol. 20: 1846-1854.
5. Lellek, H., R. Kirsten, I. Diehl, F. Apostel, F. Buck, and J. Greeve. 2000. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J. Biol. Chem. 275: 19848-19856.
6. Blanc, V., and N. O. Davidson. 2003. C-to-U RNA editing: mechanisms leading to genetic diversity. J. Biol. Chem. 278: 1395-1398.
7. Greeve, J., I. Altkemper, J. H. Dieterich, H. Greten, and E. Windler. 1993. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J. Lipid Res. 34: 1367-1383.
8. Powell, L. M., S. C. Wallis, R. J. Pease, Y. H. Edwards, T. J. Knott, and J. Scott. 1987. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell. 50: 831-840.
9. Hirano, K., S. G. Young, R. V. Farese, Jr., J. Ng, E. Sande, C. Warburton, L. M. Powell-Braxton, and N. O. Davidson. 1996. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 271: 9887-9890.
10. Nakamuta, M., B. H. Chang, E. Zsigmond, K. Kobayashi, H. Lei, B. Y. Ishida, K. Oka, E. Li, and L. Chan. 1996. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. J. Biol. Chem. 271: 25981-25988.
11. Lo, C. M., B. K. Nordskog, A. M. Nauli, S. Zheng, S. B. Vonlehmden, Q. Yang, D. Lee, L. L. Swift, N. O. Davidson, and P. Tso. 2008. Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation? Am. J. Physiol. Gastrointest. Liver Physiol. 294: G344-G352.
12. Yamanaka, S., M. E. Balestra, L. D. Ferrell, J. Fan, K. S. Arnold, S. Taylor, J. M. Taylor, and T. L. Innerarity. 1995. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. USA. 92: 8483-8487.
13. Sowden, M., J. K. Hamm, and H. C. Smith. 1996. Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing. J. Biol. Chem. 271: 3011-3017.
14. Siddiqui, J. F., D. Van Mater, M. P. Sowden, and H. C. Smith. 1999. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity. Exp. Cell Res. 252: 154-164.
15. Galloway, C. A., and H. C. Smith. 2010. The expression of apoB mRNA editing factors is not the sole determinant for the induction of editing in differentiating Caco-2 cells. Biochem. Biophys. Res. Commun. 391: 659-663.
16. Pinto, D., S. Robine, F. Jaisser, F. E. El Marjou, and D. Louvard. 1999. Regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines. J. Biol. Chem. 274: 6476-6482.
17. Blanc, V., and N. O. Davidson. 2011. Mouse and other rodent models of C to U RNA editing. Methods Mol. Biol. 718: 121-135.
18. Xie, Y., F. Nassir, J. Luo, K. Buhman, and N. O. Davidson. 2003. Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G735-G746.
19. Millar, J. S., D. A. Cromley, M. G. McCoy, D. J. Rader, and J. T. Billheimer. 2005. Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339. J. Lipid Res. 46: 2023-2028.
20. Yamanaka, S., K. S. Poksay, D. M. Driscoll, and T. L. Innerarity. 1996. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J. Biol. Chem. 271: 11506-11510.
21. Qian, X., M. E. Balestra, S. Yamanaka, J. Boren, I. Lee, and T. L. Innerarity. 1998. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. Arterioscler. Thromb. Vasc. Biol. 18: 1013-1020.
22. Hersberger, M., S. Patarroyo-White, X. Qian, K. S. Arnold, L. Rohrer, M. E. Balestra, and T. L. Innerarity. 2003. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting. Biochem. J. 369: 255-262.
23. Sowden, M., J. K. Hamm, S. Spinelli, and H. C. Smith. 1996. Determinants involved in regulating the proportion of edited apolipoprotein B RNAs. RNA. 2: 274-288.
24. Sowden, M. P., M. J. Eagleton, and H. C. Smith. 1998. Apolipoprotein B RNA sequence 3 ? of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing. Nucleic Acids Res. 26: 1644-1652.
25. Backus, J. W., and H. C. Smith. 1992. Three distinct RNA sequence elements are required for efficient apolipoprotein B (apoB) RNA editing in vitro. Nucleic Acids Res. 20: 6007-6014.
26. Smith, H. C. 1993. Apolipoprotein B mRNA editing: the sequence to the event. Semin. Cell Biol. 4: 267-278.
27. Navaratnam, N., D. Patel, R. R. Shah, J. C. Greeve, L. M. Powell, T. J. Knott, and J. Scott. 1991. An additional editing site is present in apolipoprotein B mRNA. Nucleic Acids Res. 19: 1741-1744.
28. Chen, Z., T. L. Eggerman, A. V. Bocharov, I. N. Baranova, T. G. Vishnyakova, R. J. Kurlander, G. Csako, and A. P. Patterson. 2012. Hypermutation of ApoB mRNA by rat APOBEC-1 overexpression mimics APOBEC-3 hypermutation. J. Mol. Biol. 418: 65-81.
29. Rosenberg, B. R., C. E. Hamilton, M. M. Mwangi, S. Dewell, and F. N. Papavasiliou. 2011. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3&prime UTRs. Nat. Struct. Mol. Biol. 18: 230-236.
30. Farese, R. V., Jr., M. M. Veniant, C. M. Cham, L. M. Flynn, V. Pierotti, J. F. Loring, M. Traber, S. Ruland, R. S. Stokowski, D. Huszar, et al. 1996. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc. Natl. Acad. Sci. USA. 93: 6393-6398.
31. Sundaram, M., and Z. Yao. 2010. Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion. Nutr. Metab. (Lond). 7: 35.
32. Reboul, E., D. Trompier, M. Moussa, A. Klein, J. F. Landrier, G. Chimini, and P. Borel. 2009. ATP-binding cassette transporter A1 is significantly involved in the intestinal absorption of alpha- and gamma-tocopherol but not in that of retinyl palmitate in mice. Am. J. Clin. Nutr. 89: 177-184.
33. Iqbal, J., and M. M. Hussain. 2005. Evidence for multiple complementary pathways for efficient cholesterol absorption in mice. J. Lipid Res. 46: 1491-1501.
34. Li, M., I. X. Wang, Y. Li, A. Bruzel, A. L. Richards, J. M. Toung, and V. G. Cheung. 2011. Widespread RNA and DNA sequence differences in the human transcriptome. Science. 333: 53-58.
35. Pickrell, J. K., Y. Gilad, and J. K. Pritchard. 2012. Comment on "Widespread RNA and DNA sequence differences in the human transcriptome". Science. 335: 1302; author reply 1302.
36. Lin, W., R. Piskol, M. H. Tan, and J. B. Li. 2012. Comment on "Widespread RNA and DNA sequence differences in the human transcriptome". Science. 335: 1302, author reply 1302.
37. Gu, T., F. W. Buaas, A. K. Simons, C. L. Ackert-Bicknell, R. E. Braun, and M. A. Hibbs. 2012. Canonical A-to-I and C-to-U RNA editing is enriched at 3′UTRs and microRNA target sites in multiple mouse tissues. PLoS ONE. 7: e33720.